The benzodiazepine antagonist flumazenil blocks the effects of CCK receptor agonists and antagonists in the elevated plus-maze

199362 citationsJournal Article

Authors

Good health and well-being

Published in: Psychopharmacology

Volume 110, Issue 4, pp. 409-414

Field-Weighted Citation Impact: 2.38